Cancer Family
Eye Neoplasm
CI-CAN-00000017Explore in graph →
Non-malignant86 active trials2 approved drugs19 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000017Explore in graph →
Clinical trials
463 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01906814 | Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation | unknown | Phase 3 | 179 | Sun Yat-sen UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT02137928 | Carboplatin Periocular Injection for Retinoblastoma | unknown | Phase 3 | 50 | Sun Yat-sen UniversityOTHER | 1 | Dec 19, 2014 | clinicaltrials |
| NCT00811200 |
| Treatment Of Radiation Retinopathy Trial(TORR) |
| unknown |
| Phase 2 / Phase 3 |
| 220 |
| Leiden University Medical CenterOTHER |
| 0 |
| Jul 2, 2009 |
| clinicaltrials |
| NCT00000124 | Collaborative Ocular Melanoma Study (COMS) | unknown | Phase 3 | — | National Eye Institute (NEI)NIH | 0 | Jun 2, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Apr 9, 2024source: clinicaltrials